Stephanie Greer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stephanie Greer has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alison Figueroa Almeda
Division of Oncology Department of Medicine Stanford University School of Medicine 94305 Stanford CA United States
3 shared publications - Anna C. Hooker
Division of Oncology Department of Medicine Stanford University School of Medicine 94305 Stanford CA United States
3 shared publications - Cindy Ma
Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California
3 shared publications - GiWon Shin
Division of Oncology Department of Medicine Stanford University School of Medicine 94305 Stanford CA United States
3 shared publications - Hanlee P. Ji
Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, USA
3 shared publications - HoJoon Lee
Division of Oncology Department of Medicine Stanford University School of Medicine 94305 Stanford CA United States
3 shared publications
Latest Publications
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
Supplementary Data from The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
Supplementary Data from The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
Supplementary Data from The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
Supplementary Data from The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
- Open Access
- 30 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 31 (9) , 1693-1700
The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
Background: Gastric cancer is a leading cause of cancer morbidity and mortality. Developing information systems which integrate clinical and genomic data may accelerate discoveries to improve cancer prevention, detection, and treatment. To support translational research in gastric cancer, we developed the Gastric Cancer Registry (GCR), a North American repository of clinical and cancer genomics data. Methods: Participants self-enrolled online. Entry criteria into the GCR included the following: (i) diagnosis of gastric cancer, (ii) history of gastric cancer in a first- or second-degree relative, or (iii) known germline mutation in the gene CDH1. Participants provided demographic and clinical information through a detailed survey. Some participants provided specimens of saliva and tumor samples. Tumor samples underwent exome sequencing, whole-genome sequencing, and transcriptome sequencing. Results: From 2011 to 2021, 567 individuals registered and returned the clinical questionnaire. For this cohort 65% had a personal history of gastric cancer, 36% reported a family history of gastric cancer, and 14% had a germline CDH1 mutation. 89 patients with gastric cancer provided tumor samples. For the initial study, 41 tumors were sequenced using next-generation sequencing. The data was analyzed for cancer mutations, copy-number variations, gene expression, microbiome, neoantigens, immune infiltrates, and other features. We developed a searchable, web-based interface (the GCR Genome Explorer) to enable researchers’ access to these datasets. Conclusions: The GCR is a unique, North American gastric cancer registry which integrates clinical and genomic annotation. Impact: Available for researchers through an open access, web-based explorer, the GCR Genome Explorer will accelerate collaborative gastric cancer research across the United States and world.
- 30 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 31 (9) , 1693-1700
Open AccessThe Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
Background: Gastric cancer is a leading cause of cancer morbidity and mortality. Developing information systems which integrate clinical and genomic data may accelerate discoveries to improve cancer prevention, detection, and treatment. To support translational research in gastric cancer, we developed the Gastric Cancer Registry (GCR), a North American repository of clinical and cancer genomics data. Methods: Participants self-enrolled online. Entry criteria into the GCR included the following: (i) diagnosis of gastric cancer, (ii) history of gastric cancer in a first- or second-degree relative, or (iii) known germline mutation in the gene CDH1. Participants provided demographic and clinical information through a detailed survey. Some participants provided specimens of saliva and tumor samples. Tumor samples underwent exome sequencing, whole-genome sequencing, and transcriptome sequencing. Results: From 2011 to 2021, 567 individuals registered and returned the clinical questionnaire. For this cohort 65% had a personal history of gastric cancer, 36% reported a family history of gastric cancer, and 14% had a germline CDH1 mutation. 89 patients with gastric cancer provided tumor samples. For the initial study, 41 tumors were sequenced using next-generation sequencing. The data was analyzed for cancer mutations, copy-number variations, gene expression, microbiome, neoantigens, immune infiltrates, and other features. We developed a searchable, web-based interface (the GCR Genome Explorer) to enable researchers’ access to these datasets. Conclusions: The GCR is a unique, North American gastric cancer registry which integrates clinical and genomic annotation. Impact: Available for researchers through an open access, web-based explorer, the GCR Genome Explorer will accelerate collaborative gastric cancer research across the United States and world.